Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States

BACKGROUND: The efficacy and safety of eptinezumab for preventive migraine treatment in adults have been demonstrated in multiple, large-scale clinical trials. This non-interventional, retrospective, observational chart review was conducted to examine patient response to eptinezumab 100 mg or 300 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Starling, Amaal J., Kymes, Steven, Asher, Divya, Soni-Brahmbhatt, Seema, Karnik-Henry, Meghana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116681/
https://www.ncbi.nlm.nih.gov/pubmed/37081405
http://dx.doi.org/10.1186/s12883-023-03204-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116681/
https://www.ncbi.nlm.nih.gov/pubmed/37081405
http://dx.doi.org/10.1186/s12883-023-03204-8

Ejemplares similares